These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 20626687)

  • 1. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC; Maynard AD
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
    Thomas T; Bahadori T; Savage N; Thomas K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials--part A.
    Methner M; Hodson L; Geraci C
    J Occup Environ Hyg; 2010 Mar; 7(3):127-32. PubMed ID: 20017054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of engineered nanoparticles in food and the environment.
    Tiede K; Boxall AB; Tear SP; Lewis J; David H; Hassellov M
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Jul; 25(7):795-821. PubMed ID: 18569000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
    Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
    Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of predictive computational models for nanoparticle-induced cytotoxicity.
    Sayes C; Ivanov I
    Risk Anal; 2010 Nov; 30(11):1723-34. PubMed ID: 20561263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials and the environment: uses, methods and measurement.
    Carl Englert B
    J Environ Monit; 2007 Nov; 9(11):1154-61. PubMed ID: 17968441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health risks of engineered nanomaterials and nanotechnologies].
    Savolainen K; Vainio H
    Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health effects of inhaled engineered and incidental nanoparticles.
    Madl AK; Pinkerton KE
    Crit Rev Toxicol; 2009; 39(8):629-58. PubMed ID: 19743943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors.
    Nowack B; Brouwer C; Geertsma RE; Heugens EH; Ross BL; Toufektsian MC; Wijnhoven SW; Aitken RJ
    Nanotoxicology; 2013 Sep; 7(6):1152-6. PubMed ID: 22783888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health effects of engineered nanomaterials].
    Pietroiusti A; Magrini A; Bergamaschi A; Iavicoli I
    G Ital Med Lav Ergon; 2010; 32(4 Suppl):287-9. PubMed ID: 21438282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk management of nanomaterials.
    Gwinn MR; Tran L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):130-7. PubMed ID: 20077523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.
    Borm P; Klaessig FC; Landry TD; Moudgil B; Pauluhn J; Thomas K; Trottier R; Wood S
    Toxicol Sci; 2006 Mar; 90(1):23-32. PubMed ID: 16396841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.